References
- Tozawa K, Sagawa M, Kizaki M. Quinone methide tripterine, celastrol, induces apoptosis in human myeloma cells via NF-κB pathway. Int J Oncol 2011;39:1117–22.
- Jiang QW, Cheng KJ, Mei XL, et al. Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine. Oncotarget 2015;6:32790–804.
- Yu X, Zhou X, Fu C, et al. Celastrol induces apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway. Oncol Rep 2015;34:1129–36.
- Zheng L, Fu Y, Zhuang L, et al. Simultaneous NF-κB inhibition and E-cadherin upregulation mediate mutually synergistic anticancer activity of celastrol and SAHA in vitro and in vivo. Int J Cancer 2014;135:1721–32.
- Luo DQ, Wang H, Tian X, et al. Antifungal properties of pristimerin and celastrol isolated from Celastrus hypoleucus. Pest Manag Sci 2005;61:85–90.
- Divya T, Dineshbabu V, Soumyakrishnan S, et al. Celastrol enhances Nrf2 mediated antioxidant enzymes and exhibits anti-fibrotic effect through regulation of collagen production against bleomycin-induced pulmonary fibrosis. Chem Biol Interact 2016;246:52–62.
- Jia Z, Xu C, Shen J, et al. The natural compound celastrol inhibits necroptosis and alleviates ulcerative colitis in mice. Int Immunopharmacol 2015;29:552–9.
- Yang L, Li Y, Ren J, et al. Celastrol attenuates inflammatory and neuropathic pain mediated by cannabinoid receptor type 2. Int J Mol Sci 2014;15:13637–48.
- Wang C, Shi C, Yang X, et al. Celastrol suppresses obesity process via increasing antioxidant capacity and improving lipid metabolism. Eur J Pharmacol 2014;744:52–8.
- Paris D, Ganey NJ, Laporte V, et al. Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer’s disease. J Neuroinflammation 2010;7:17.
- Tang WJ, Wang J, Tong X, et al. Design and synthesis of celastrol derivatives as anticancer agents. Eur J Med Chem 2015;95:166–73.
- Jiang F, Wang HJ, Bao QC, et al. Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties. Bioorg Med Chem 2016;24:5431–9.
- Klaić L, Morimoto RI, Silverman RB. Celastrol analogues as inducers of the heat shock response. Design and synthesis of affinity probes for the identification of protein targets. ACS Chem Biol 2012;7:928–37.
- Tang K, Huang Q, Zeng J, et al. Design, synthesis and biological evaluation of C6-modified celastrol derivatives as potential antitumor agents. Molecules 2014;19:10177–88.
- Iwaszkiewicz-Grzes D, Cholewinski G, Kot-Wasik A, et al. Synthesis and biological activity of mycophenolic acid-amino acid derivatives. Eur J Med Chem 2013;69:863–71.
- Voynikov Y, Valcheva V, Momekov G, et al. Theophylline-7-acetic acid derivatives with amino acids as anti-tuberculosis agents. Bioorg Med Chem Lett 2014;24:3043–5.
- Moon PD, Kim KY, Rew KH, et al. Anti-fatigue effects of porcine placenta and its amino acids in a behavioral test on mice. Can J Physiol Pharmacol 2014;92:937–44.
- Hicks RP, Abercrombie JJ, Wong RK, Leung KP. Antimicrobial peptides containing unnatural amino acid exhibit potent bactericidal activity against ESKAPE pathogens. Bioorg Med Chem 2013;21:205–14.
- Jensen CM, Chow HQ, Chen M, et al. Iminolactones as tools for inversion of the absolute configuration of α-amino acids and as inhibitors of cancer cell proliferation. Eur J Med Chem 2016;114:118–33.
- Staykova STs, Wesselinova DW, Vezenkov LT, Naydenova ED. Synthesis and in vitro antitumor activity of new octapeptide analogs of somatostatin containing unnatural amino acids. Amino Acids 2015;47:1007–13.
- Csuk R, Niesen-Barthel A, Schafer R, et al. Synthesis and antitumor activity of ring A modified 11-keto-β-boswellic acid derivatives. Eur J Med Chem 2015;92:700–11.
- Lee MS, Chao J, Yen JC, et al. Schizandrin protects primary rat cortical cell cultures from glutamate-induced apoptosis by inhibiting activation of the MAPK family and the mitochondria dependent pathway. Molecules 2012;18:354–72.
- Fan XX, Li N, Wu JL, et al. Celastrol induces apoptosis in gefitinib-resistant non-small cell lung cancer cells via caspases-dependent pathways and Hsp90 client protein degradation. Molecules 2014;19:3508–22.
- Ahmad K, Balaramnavar VM, Baig MH, et al. Identification of potent caspase-3 inhibitors for treatment of multi- neurodegenerative diseases using pharmacophore modeling and docking approaches. CNS Neurol Disord Drug Targets 2014;13:1346–53.